Pharmacy

June 29th, 2020 | Pharmacy PearlsDiabetes

This edition of Pharmacy Pearls compares the CV outcome study characteristics and results for both the glucagon-like peptide-1 receptor agonist (GLP-1 RA) and sodium glucose cotransporter 2 (SGLT2) inhibitor classes…

Read More ›

June 16th, 2020 | Pharmacy PearlsCardiology

This edition of Pharmacy Pearls reviews the benefits of utilizing generic statins for treatment of hyperlipidemia, as certain brand-name statins can reach almost $900 per month. Generic statins have an…

Read More ›

May 27th, 2020 | Asthma/COPDPharmacy Pearls

In the following edition of Pharmacy Pearls, the AHP Pharmacy Team has reviewed and presents the 2020 GOLD guidelines for COPD management, focusing on medication therapy. There is also information…

Read More ›

May 8th, 2020 | Asthma/COPDPharmacy Pearls

This edition of Pharmacy Pearls reviews medication management of asthma- in children, adults, and how management is affected by the COVID-19 pandemic. You will also find inhaler device technique steps…

Read More ›

May 8th, 2020 | Asthma/COPDPharmacy Pearls

This edition of Pharmacy Pearls reviews medication management of asthma- in children, adults, and how management is affected by the COVID-19 pandemic. You will also find inhaler device technique steps…

Read More ›

May 8th, 2020 | Asthma/COPDPharmacy Pearls

This edition of Pharmacy Pearls reviews medication management of asthma- in children, adults, and how management is affected by the COVID-19 pandemic. You will also find inhaler device technique steps…

Read More ›

March 31st, 2020 | Pharmacy PearlsInfectious Diseases

Click the link here to download a PDF of COVID-19 Pharmacy Pearls.

March 3rd, 2020 | Asthma/COPDPharmacy Pearls

In this edition of Pharmacy Pearls, we have updated our inhaler chart to include a new generic ICS/LABA that has come to market. Budesonide/formoterol, an authorized generic of Symbicort, is…

Read More ›

February 5th, 2020 | Pharmacy PearlsCardiology

This edition of Pharmacy Pearls critically reviews the data of the REDUCE-IT trial for Vascepa, which resulted in its new FDA-labeled indication for cardiovascular risk reduction with mild hypertriglyceridemia. We…

Read More ›

January 24th, 2020 | Pharmacy PearlsInfectious Diseases

According to the CDC, Influenza B/Victoria viruses are predominant nationally, which is unusual for this time of year. H1N1 viruses are the next most common. H3N2 and B/Yamagata viruses are…

Read More ›